Charles River Laboratories International (CRL) FCF Margin (2009 - 2025)
Charles River Laboratories International (CRL) posted quarterly FCF Margin of 5.89% for Q4 2025, down 246.0% year-over-year from 4.03% in Q4 2024, and down 66.79% quarter-over-quarter from 17.74% in Q3 2025.
Charles River Laboratories International (CRL) FCF Margin (2009 - 2025) Analysis & Trends
Charles River Laboratories International's FCF Margin history runs 17 years deep, the most recent figure standing at 5.89% for Q4 2025.
- In Q4 2025, FCF Margin fell 246.0% year-over-year to 5.89%; the TTM figure through Dec 2025 stood at 12.91% (up 53.0% YoY), while the FY2025 annual figure was 12.91%, up 53.0% from the prior year.
- FCF Margin for Q4 2025 stood at 5.89%, down from 17.74% in the prior quarter.
- The five-year high for FCF Margin was 21.1% in Q3 2024, with the low at 0.24% in Q2 2023.
- The 5-year median for FCF Margin is 13.28% (2021), against an average of 11.27%.
- The sharpest annual moves came in 2021 and 2022: FCF Margin soared 1118 bps in 2021, then tumbled 1482 bps in 2022.
- Charles River Laboratories International's FCF Margin stood at 14.42% in 2021, then decreased by 8 bps to 13.25% in 2022, then increased by 6 bps to 14.07% in 2023, then tumbled by 41 bps to 8.35% in 2024, then retreated by 29 bps to 5.89% in 2025.
- Business Quant data shows CRL's FCF Margin at 5.89% in Q4 2025, 17.74% in Q3 2025, and 16.4% in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 13.97% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 20.19% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 26.51% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 10.95% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 8.24% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 2.59% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 13.89% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 27.51% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.08% |
| 10 | Charles River Laboratories International | 12.89 Bn | 12.68 Bn | 1.81 Bn | 5.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | 5.89% |
| Sep 27, 2025 | 17.74% |
| Jun 28, 2025 | 16.40% |
| Mar 29, 2025 | 11.42% |
| Dec 28, 2024 | 8.35% |
| Sep 28, 2024 | 21.10% |
| Jun 29, 2024 | 15.01% |
| Mar 30, 2024 | 5.02% |
| Dec 30, 2023 | 14.07% |
| Sep 30, 2023 | 13.59% |
| Jul 1, 2023 | 7.62% |
| Apr 1, 2023 | 0.24% |
| Dec 31, 2022 | 13.25% |
| Sep 24, 2022 | 6.10% |
| Jun 25, 2022 | 6.85% |
| Mar 26, 2022 | 2.43% |
| Dec 25, 2021 | 14.42% |
| Sep 25, 2021 | 13.30% |
| Jun 26, 2021 | 15.32% |
| Mar 27, 2021 | 17.25% |